BEAT stock icon

Heartbeam
BEAT

$2.3
12.75%
 

About: HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Employees: 13

0
Funds holding %
of 6,689 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.05% less ownership

Funds ownership: 7.77% [Q4 2023] → 7.71% (-0.05%) [Q1 2024]

8% less capital invested

Capital invested by funds: $4.8M [Q4 2023] → $4.43M (-$372K) [Q1 2024]

19% less funds holding

Funds holding: 31 [Q4 2023] → 25 (-6) [Q1 2024]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$8
248%
upside
Avg. target
$8
248%
upside
High target
$8
248%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Benchmark
Bill Sutherland
248%upside
$8
Speculative Buy
Reiterated
13 May 2024
Benchmark
Bill Sutherland
248%upside
$8
Speculative Buy
Reiterated
25 Mar 2024

Financial journalist opinion